The Top Five Product Searches on CPHI Online: January
Which were the products that drew the most interest in the CPHI directory in January? We analyse search data from the CPHI directory…
1. Bedrolite – THC <1.0%/CBD 9% - Bedrocan
This CBD-only based product from natural API medicinal cannabis supplier Bedrocan roared straight into the top five in January to become the most searched on CPHI Online during the month.
Available in granular form, it is typically used by patients with severe, intractable forms of epilepsy. The virtual absence of THC means it does not have psychoactive properties.
2. Avoquin 4% - Avalon Pharma
This skin lightening cream finally lost its top spot this month, slipping down one place in the pecking order, but still attracting a huge amount of interest on CPHI Online.
The formulation – sold in African, Middle Eastern and Asian markets -- contains hydroquinone, which the company describes as the ‘gold standard’ for treatment of skin hyperpigmentation and claims has been proven in clinical trials to be the safest and most effective skin lightening agent.
Skin lightening refers to the practice of using chemical substances to lighten the skin or provide an even skin colour by reducing the melanin concentration. Hydroquinone is currently not approved for this purpose in Europe.
3. Avocom-M cream – Avalon Pharma
This anti-inflammatory, antipruritic and anti-allergic cream, also from Avalon Pharma, slipped one place in January. The product is a unique combination of corticosteroid, Mometasone Furoate, (0.1% concentration) and anti-fungal Miconazole Nitrate (2%).
4. Avalon Avotin -Avalon Pharma
Despite this product also slipping one place, Saudi Arabia’s Avalon retains its record of having three products occupying top five positions. This formulation of Tretinoin cream, a derivative of vitamin A, was a new entry in December. It is a versatile retinoid that works by increasing the growth rate of skin cells and is used to treat a variety of skin conditions, from acne to aging.
5. Trofocard & Trofocard Max - Uni-Pharma
Uni-Pharma’s Spasmo-Apotel fell out of the top five in January, but the Greek company managed to replace it with one of their other products. Trofocard is a dietary supplement for magnesium deficiency and is available in gastro-resistant tablets, injectable solution and film-coated tablets.
Related News
-
News Women in Pharma: Hiring Across the Gender Divide
In our monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
Sponsored Content Ashwagandha and Herbal Medicines: Pharma’s Next Big Opportunity
Herbal medicines and nutraceuticals have seen a surge in interest since the onset of the COVID-19 pandemic. Driven by patient interest in prioritising personalised and integrative medicines, the herbal ingredients industry is now faced with concerns pe... -
News Identifying Alzheimer’s Disease biomarker proteins with whole blood tests
A University of Manchester spin-out pharmaceutical company, PharmaKure, has reported successful study results for the quantification of Alzheimer’s Disease biomarker proteins with a whole blood test. -
News Bill & Melinda Gates Foundation to boost mRNA vaccine initiatives in Africa with USD $40m
To address vaccine inequality and accessibility issues, the Bill & Melinda Gates Foundation aims to deliver USD $40m to various biotech companies and vaccine manufacturers in support of mRNA vaccine development. -
News Updated – Changing abortion pill access according to the US FDA and Supreme Court
After the approval of the medical abortion pill, mifepristone, by the US FDA, states across the USA approach the distribution of the pill differently, some ruling against allowing access to the drug. -
News Revolutionising cancer treatment with mRNA-based therapeutics
Global market for mRNA-based oncology therapeutics expected to reach USD $2 billion by 2029, with promising results for the combination of mRNA candidates with immune checkpoint inhibitors to treat solid tumours. -
News Breaking Barriers: Innovations in Oral Solid Dose Form Bioavailability
The effectiveness of a medication often hinges on its bioavailability – the rate and extent at which the active ingredient is absorbed into the bloodstream. When it comes to oral solid dose forms, such as tablets and capsules, the challenge lies ... -
News Choosing the Right CDMO Partner: A Comprehensive Guide
Finding the right partner for the development and manufacturing of your pharmaceutical or biopharmaceutical products is paramount. This is where Contract Development and Manufacturing Organizations (CDMOs) step in, offering their expertise and infrastr...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance